Official announcements
messages in brief
Veterinary Medicines
|
03/10/2023
With the entry into force of Regulation (EU) 2019/6, medicinal products for certain pet animals, which were previously not subject to a marketing authorization requirement under Section 7(4) of the AMG, may now only be marketed in Germany if they have been notified to the BASG.
Safety warnings
|
Blood & Tissue
|
03/10/2023
The Federal Office for Safety in Health Care has been informed by the Italian authority that, in addition to the provinces already announced, ID WNV NAT testing for donations of blood and blood components has been introduced in the province of Cosenza.
Recall
|
Veterinary Medicines
|
02/10/2023
Recall due to deviations from the manufacturing protocol
Safety warnings
|
Blood & Tissue
|
02/10/2023
The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that in France, in addition to the regions already announced, human WNV infections have been recorded in the regions of Charente, Gard and Vaucluse.
Safety warnings
|
Blood & Tissue
|
02/10/2023
The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that human WNV infections have been recorded in Cáceres in Spain, in addition to the regions already announced.
Safety warnings
|
Blood & Tissue
|
02/10/2023
The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that in Greece, in addition to the regions already announced, human WNV infections have been recorded in the regions of Evros and Ioannina.
CHMP Monthly News
|
26/09/2023
Up-to-date information from the June 11.09.-14.09.2023 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
Safety warnings
|
Blood & Tissue
|
25/09/2023
The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that in Hungary, in addition to the regions already announced, confirmed human WNV infections have been recorded in the Baranya region.
Safety warnings
|
Blood & Tissue
|
25/09/2023
The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that confirmed human WNV infections have been recorded in Croatia in the regions of Brod-Posavina, Osijek-Baranja, Vukovar-Srijem and Zagreb.
Safety warnings
|
Blood & Tissue
|
25/09/2023
The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that confirmed human WNV infections have been recorded in Germany in the Sömmerda region.